Lanean...
Infección por SARS-CoV-2 y seroprevalencia en pacientes con esclerosis múltiple
INTRODUCTION: The effect of SARS-CoV-2 infection in patients with multiple sclerosis (MS) and the influence of disease-modifying therapies (DMT) for MS on COVID-19 are unknown. To date, patients with MS have not been shown to present greater risk of COVID-19 or more severe progression of the disease...
Gorde:
| Argitaratua izan da: | Neurologia |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Sociedad Española de Neurología. Published by Elsevier España, S.L.U.
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7973057/ https://ncbi.nlm.nih.gov/pubmed/33812762 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nrl.2021.03.005 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|